These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6098109)

  • 1. [Effectors of in vivo delayed hypersensitivity in experimental flavivirus infections and vaccination against tick-borne encephalitis in mice].
    Lipovka VA; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):83-8. PubMed ID: 6098109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose vaccine against tick-borne encephalitis.
    Rumyantsev AA; Goncalvez AP; Giel-Moloney M; Catalan J; Liu Y; Gao QS; Almond J; Kleanthous H; Pugachev KV
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13103-8. PubMed ID: 23858441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of macrophage barrier function in mice vaccinated against tick-borne encephalitis and infection with flaviviruses of varying virulence].
    Karaseva PS; Khotlubeĭ LI; El'bert LB; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Dec; (12):57-60. PubMed ID: 6320556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of bunyavirus- and togavirus-induced nonspecific suppressors inhibiting delayed hypersensitivity].
    Liapovka VA; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):64-6. PubMed ID: 6213121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV.
    Wang HJ; Li XF; Qin CF
    Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined effects of immunomodulators and specific inactivated vaccines against alpha- and flavivirus infections].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Med Parazitol (Mosk); 2011; (1):17-20. PubMed ID: 21480553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic mechanisms of preventing persistence of tick-borne encephalitis virus in mice].
    Khozinskiĭ VV; Semenov BF
    Vopr Virusol; 1989; 34(5):585-90. PubMed ID: 2532810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
    Aberle JH; Aberle SW; Kofler RM; Mandl CW
    J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2 restricted regulation by soluble autoantigens of the tick-borne encephalitis virus-induced autoreactive T-effector and T-suppressor lymphocytes in mice.
    Khozinsky VV; Semenov BF
    Acta Virol; 1986 Jan; 30(1):35-44. PubMed ID: 2871731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.
    Schwaiger J; Aberle JH; Stiasny K; Knapp B; Schreiner W; Fae I; Fischer G; Scheinost O; Chmelik V; Heinz FX
    J Virol; 2014 Jul; 88(14):7828-42. PubMed ID: 24789782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on preparation of a tick-borne encephalitis (TBE) vaccine from the Skalica strain.
    Gresíková M; Sekeyová M; Marcinka K; Ciampor F
    Acta Virol; 1986 May; 30(3):243-8. PubMed ID: 2874729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.